{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:52:09Z","timestamp":1760237529906,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The coexistence of pyoderma gangrenosum (PG) and gout has been reported in individual patients; however, the association between these conditions has not been investigated. We aimed to assess the association between PG and gout and to examine whether the presence of gout predisposes to the development of PG. A population-based case-control study was conducted comparing PG patients (n = 302) with age-, sex-, and ethnicity-matched control subjects (n = 1497) with respect to the presence of preceding gout. Logistic regression models were utilized for univariate and multivariate analyses. The prevalence of preceding gout was greater in patients with PG than in control subjects (3.7% vs. 0.7%, respectively; p &lt; 0.001). Gout was associated with a more than fivefold increase in the risk of PG (OR, 5.15; 95% CI, 2.21\u201311.98). After adjusting for confounding factors, gout emerged as a significant independent predictor of PG (adjusted OR, 4.08; 95% CI, 1.69\u20139.80). Gout preceded the diagnosis of PG by a median latency of 4.6 years. Patients with gout-associated PG were older, predominantly male, and had a higher prevalence of metabolic syndrome than other patients with PG. In conclusion, gout increases the risk of developing PG by more than fivefold. Physicians managing patients with gout and PG should be aware of this emerging association.<\/jats:p>","DOI":"10.3390\/jcm9061626","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:44:02Z","timestamp":1590713042000},"page":"1626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Is Gout Associated with Pyoderma Gangrenosum? A Population-Based Case-Control Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck, 23562 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Tzur Bitan","sequence":"additional","affiliation":[{"name":"Department of Behavioral Sciences, Ariel University, 40700 Ariel, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhammad","family":"Kridin","sequence":"additional","affiliation":[{"name":"Sackler School of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-6505","authenticated-orcid":false,"given":"Giovanni","family":"Damiani","sequence":"additional","affiliation":[{"name":"Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy"},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Clalit Health Services, 6264705 Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative Pyoderma Gangrenosum: A Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kridin, K., Cohen, A.D., and Amber, K.T. (2018). Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am. J. Clin. Dermatol.","DOI":"10.1007\/s40257-018-0356-7"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1610-0387.2007.0328.x","article-title":"Pyoderma gangrenosum: Clinical presentation and outcome in 18 cases and review of the literature","volume":"5","author":"Hasselmann","year":"2007","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cabalag, M.S., Wasiak, J., Lim, S.W., and Raiola, F.B. (2015). Inpatient Management of Pyoderma Gangrenosum: Treatments, Outcomes, and Clinical Implications. Ann. Plast. Surg.","DOI":"10.1097\/SAP.0b013e31829565f3"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vallerand, I.A., and Hardin, J. (2019). Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report. SAGE Open Med. Case Reports, 7.","DOI":"10.1177\/2050313X19845206"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ye, M.J., and Ye, J.M. (2014). Pyoderma gangrenosum: A review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol. Res. Pract.","DOI":"10.1155\/2014\/461467"},{"key":"ref_9","first-page":"204","article-title":"The quality indigators program in Clalit Health Services: The first decade","volume":"149","author":"Cohen","year":"2010","journal-title":"Harefuah"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and Metabolic Syndrome: A Tangled Web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_12","first-page":"3143","article-title":"Third Report of the National Cholesterol Education Program Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"Grundy","year":"2001","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jdv.15642","article-title":"Atopic dermatitis and the metabolic syndrome: A cross-sectional study of 116 816 patients","volume":"33","author":"Shalom","year":"2019","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1572-0241.2004.04039.x","article-title":"Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis","volume":"99","author":"Manguso","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"States, V., O\u2019Brien, S., Rai, J.P., Roberts, H.L., Paas, M., Feagins, K., Pierce, E.J., Baumgartner, R.N., and Galandiuk, S. (2020). Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Dig. Dis. Sci.","DOI":"10.1007\/s10620-019-05999-4"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Roberts, H., Rai, S.N., Pan, J., Rao, J.M., Keskey, R.C., Kanaan, Z., Short, E.P., Mottern, E., and Galandiuk, S. (2014). Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion.","DOI":"10.1159\/000363228"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Karmiris, K., Avgerinos, A., Tavernaraki, A., Zeglinas, C., Karatzas, P., Koukouratos, T., Oikonomou, K.A., Kostas, A., Zampeli, E., and Polymeros, D. (2016). Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J. Crohn\u2019s Colitis.","DOI":"10.1093\/ecco-jcc\/jjv232"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gaviria, J.L., Ortega, V.G., Gaona, J., Motta, A., and Barrag\u00e1n, O.J.M. (2015). Unusual dermatological manifestations of gout: Review of literature and a case report. Plast. Reconstr. Surg. Glob. Open.","DOI":"10.1097\/GOX.0000000000000420"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ashchyan, H.J., Butler, D.C., Nelson, C.A., Noe, M.H., Tsiaras, W.G., Lockwood, S.J., James, W.D., Micheletti, R.G., Rosenbach, M., and Mostaghimi, A. (2018). The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum. JAMA Dermatol.","DOI":"10.1001\/jamadermatol.2017.5978"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10408360290795448","article-title":"Clinical significance of cytokine determination in synovial fluid","volume":"39","author":"Punzi","year":"2002","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12016-012-8351-x","article-title":"Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet\u2019s syndrome: A comprehensive review and disease classification criteria","volume":"45","author":"Marzano","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_23","unstructured":"Ganson, N.J., Kelly, S.J., Scarlett, E., Sundy, J.S., and Hershfield, M.S. (2005). Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kim, H.A., Seo, Y.I., Lee, J., and Jung, Y.O. (2016). Detection of Anti-Type II Collagen Antibodies in Patients with Chronic Gouty Arthritis: Findings from a Pilot Study. J. Clin. Rheumatol.","DOI":"10.1097\/RHU.0000000000000438"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/oxfordjournals.aje.a113439","article-title":"On the need for the rare disease assumption in case-control studies","volume":"116","author":"Greenland","year":"1982","journal-title":"Am. J. Epidemiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:33:20Z","timestamp":1760175200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/6\/1626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["jcm9061626"],"URL":"https:\/\/doi.org\/10.3390\/jcm9061626","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}